KIR2DL1 and COVID-19: Finally, we also assessed the ability of NKG2A and KIR2DL1 blockade to enhance the cytotoxic activity of NK cells from patients who were COVID-19 negative against spike expressing infected CACO-2 cells (Supplemental Figure 3).